Publications in collaboration with researchers from Hospital del Mar (27)

2025

  1. Revascularization and outcomes in ischaemic left ventricular dysfunction after heart failure admission: The RevascHeart study

    European Journal of Heart Failure, Vol. 27, Núm. 3, pp. 598-605

2024

  1. OPTImized coronary interventions eXplaIn the bEst cliNical outcomEs (OPTI-XIENCE) study. Rationale and study design

    Cardiovascular Revascularization Medicine, Vol. 59, pp. 93-98

  2. TRPV4 Channels Promote Pathological, but Not Physiological, Cardiac Remodeling through the Activation of Calcineurin/NFAT and TRPC6

    International Journal of Molecular Sciences, Vol. 25, Núm. 3

2023

  1. Very long-term efficacy and safety of paclitaxel-eluting balloon after a bare-metal stent for the treatment of ST-elevation myocardial infarction: 8-year results of a randomized clinical trial (PEBSI study)

    Cardiovascular Diagnosis and Therapy, Vol. 13, Núm. 5

2022

  1. Amphilimus- vs. zotarolimus-eluting stents in patients with diabetes mellitus and coronary artery disease: The SUGAR trial

    European Heart Journal, Vol. 43, Núm. 13, pp. 1320-1330

  2. Instantaneous Wave-Free Ratio for the Assessment of Intermediate Left Main Coronary Artery Stenosis: Correlations with Fractional Flow Reserve/Intravascular Ultrasound and Prognostic Implications: The iLITRO-EPIC07 Study

    Circulation: Cardiovascular Interventions, Vol. 15, Núm. 11, pp. 861-871

  3. Sacubitril/valsartan affects pulmonary arterial pressure in heart failure with preserved ejection fraction and pulmonary hypertension

    ESC Heart Failure, Vol. 9, Núm. 4, pp. 2170-2180

2021

  1. Antithrombotic strategies in elderly patients with atrial fibrillation revascularized with drug-eluting stents: PACO-PCI (EPIC-15) registry

    International Journal of Cardiology, Vol. 338, pp. 63-71

  2. Consequences of canceling elective invasive cardiac procedures during Covid-19 outbreak

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 5, pp. 927-937

  3. Impact of diabetes in patients waiting for invasive cardiac procedures during COVID-19 pandemic

    Cardiovascular Diabetology, Vol. 20, Núm. 1

  4. Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes

    Catheterization and Cardiovascular Interventions, Vol. 97, Núm. 3, pp. 376-383

2020

  1. Economic analysis of intermittent intravenous outpatient treatment with levosimendan in advanced heart failure in Spain

    Revista Espanola de Cardiologia, Vol. 73, Núm. 5, pp. 361-367

  2. Impact of COVID-19 on ST-segment elevation myocardial infarction care. The Spanish experience

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 994-1002

  3. Improved Diagnosis of Rare Disease Patients through Systematic Detection of Runs of Homozygosity

    Journal of Molecular Diagnostics, Vol. 22, Núm. 9, pp. 1205-1215

  4. Sex-based differences in chronic total occlusion management and long-term clinical outcomes

    International Journal of Cardiology, Vol. 319, pp. 46-51

2019

  1. Invasive Versus Conservative Strategy in Frail Patients With NSTEMI: The MOSCA-FRAIL Clinical Trial Study Design

    Revista Espanola de Cardiologia, Vol. 72, Núm. 2, pp. 154-159

2018

  1. Angina and Ischemia at 2 Years With Bioresorbable Vascular Scaffolds and Metallic Drug-eluting Stents. ESTROFA Ischemia BVS-mDES Study

    Revista Espanola de Cardiologia, Vol. 71, Núm. 5, pp. 327-334

  2. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial

    European Journal of Heart Failure, Vol. 20, Núm. 7, pp. 1128-1136

2016

  1. No benefit from the obesity paradox for diabetic patients with heart failure

    European Journal of Heart Failure, Vol. 18, Núm. 7, pp. 851-858

2015

  1. The titan-ami multicenter registry evaluating the usage of titan2 stent in patients with ST segment elevation myocardial infarction. Final result at 12-month follow-up

    Minerva Cardioangiologica, Vol. 63, Núm. 1, pp. 11-20